Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.10
DVA's Cash-to-Debt is ranked lower than
73% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. DVA: 0.10 )
Ranked among companies with meaningful Cash-to-Debt only.
DVA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.12 Max: 5.2
Current: 0.1
0
5.2
Equity-to-Asset 0.26
DVA's Equity-to-Asset is ranked lower than
82% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. DVA: 0.26 )
Ranked among companies with meaningful Equity-to-Asset only.
DVA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.35  Med: 0.25 Max: 0.7
Current: 0.26
-0.35
0.7
Debt-to-Equity 1.79
DVA's Debt-to-Equity is ranked lower than
85% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. DVA: 1.79 )
Ranked among companies with meaningful Debt-to-Equity only.
DVA' s Debt-to-Equity Range Over the Past 10 Years
Min: -4.75  Med: 2.06 Max: 27.14
Current: 1.79
-4.75
27.14
Debt-to-EBITDA 2.81
DVA's Debt-to-EBITDA is ranked higher than
51% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. DVA: 2.81 )
Ranked among companies with meaningful Debt-to-EBITDA only.
DVA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.81  Med: 3.58 Max: 5.24
Current: 2.81
2.81
5.24
Interest Coverage 5.86
DVA's Interest Coverage is ranked lower than
58% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. DVA: 5.86 )
Ranked among companies with meaningful Interest Coverage only.
DVA' s Interest Coverage Range Over the Past 10 Years
Min: 2.87  Med: 4.46 Max: 5.86
Current: 5.86
2.87
5.86
Piotroski F-Score: 7
Altman Z-Score: 2.04
Beneish M-Score: -2.52
WACC vs ROIC
6.02%
13.65%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 16.42
DVA's Operating Margin % is ranked higher than
79% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. DVA: 16.42 )
Ranked among companies with meaningful Operating Margin % only.
DVA' s Operating Margin % Range Over the Past 10 Years
Min: 8.49  Med: 15.37 Max: 17.15
Current: 16.42
8.49
17.15
Net Margin % 8.68
DVA's Net Margin % is ranked higher than
71% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. DVA: 8.68 )
Ranked among companies with meaningful Net Margin % only.
DVA' s Net Margin % Range Over the Past 10 Years
Min: 1.96  Med: 6.54 Max: 8.68
Current: 8.68
1.96
8.68
ROE % 26.57
DVA's ROE % is ranked higher than
91% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. DVA: 26.57 )
Ranked among companies with meaningful ROE % only.
DVA' s ROE % Range Over the Past 10 Years
Min: 5.37  Med: 19.11 Max: 26.57
Current: 26.57
5.37
26.57
ROA % 6.86
DVA's ROA % is ranked higher than
70% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. DVA: 6.86 )
Ranked among companies with meaningful ROA % only.
DVA' s ROA % Range Over the Past 10 Years
Min: 1.49  Med: 4.95 Max: 6.86
Current: 6.86
1.49
6.86
ROC (Joel Greenblatt) % 72.74
DVA's ROC (Joel Greenblatt) % is ranked higher than
83% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. DVA: 72.74 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
DVA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 38.04  Med: 56.82 Max: 72.74
Current: 72.74
38.04
72.74
3-Year Revenue Growth Rate 9.50
DVA's 3-Year Revenue Growth Rate is ranked higher than
60% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. DVA: 9.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
DVA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.8  Med: 12.7 Max: 44.8
Current: 9.5
4.8
44.8
3-Year EBITDA Growth Rate 9.70
DVA's 3-Year EBITDA Growth Rate is ranked higher than
57% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. DVA: 9.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
DVA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -38.6  Med: 15 Max: 98.2
Current: 9.7
-38.6
98.2
3-Year EPS without NRI Growth Rate 14.10
DVA's 3-Year EPS without NRI Growth Rate is ranked higher than
62% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. DVA: 14.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
DVA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -29  Med: 14.1 Max: 125.5
Current: 14.1
-29
125.5
GuruFocus has detected 2 Warning Signs with DaVita Inc DVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» DVA's 30-Y Financials

Financials (Next Earnings Date: 2017-11-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

DVA Guru Trades in Q3 2016

Joel Greenblatt 45,595 sh (New)
Warren Buffett 38,565,570 sh (unchged)
Andreas Halvorsen Sold Out
Manning & Napier Advisors, Inc 1,354,745 sh (-1.52%)
Arnold Van Den Berg 77,285 sh (-2.54%)
Jim Simons 1,313,500 sh (-4.60%)
Ray Dalio 65,300 sh (-14.05%)
Mario Gabelli 32,613 sh (-19.20%)
» More
Q4 2016

DVA Guru Trades in Q4 2016

Richard Pzena 3,327 sh (New)
Steven Cohen 283,200 sh (New)
Joel Greenblatt 440,617 sh (+866.37%)
Ray Dalio 88,244 sh (+35.14%)
Warren Buffett 38,565,570 sh (unchged)
Arnold Van Den Berg Sold Out
Mario Gabelli 21,663 sh (-33.58%)
Jim Simons 844,500 sh (-35.71%)
Manning & Napier Advisors, Inc 288,580 sh (-78.70%)
» More
Q1 2017

DVA Guru Trades in Q1 2017

Leucadia National 7,135 sh (New)
Paul Tudor Jones 461,620 sh (New)
Andreas Halvorsen 381,597 sh (New)
Ray Dalio 142,304 sh (+61.26%)
Jim Simons 1,192,900 sh (+41.26%)
Mario Gabelli 22,163 sh (+2.31%)
Warren Buffett 38,565,570 sh (unchged)
Richard Pzena 3,327 sh (unchged)
Steven Cohen Sold Out
Joel Greenblatt 357,208 sh (-18.93%)
Manning & Napier Advisors, Inc 172,000 sh (-40.40%)
» More
Q2 2017

DVA Guru Trades in Q2 2017

Steven Cohen 21,300 sh (New)
Manning & Napier Advisors, Inc 1,713,476 sh (+896.21%)
Mario Gabelli 22,763 sh (+2.71%)
Richard Pzena 3,398 sh (+2.13%)
Warren Buffett 38,565,570 sh (unchged)
Leucadia National Sold Out
Andreas Halvorsen Sold Out
Ray Dalio 64,486 sh (-54.68%)
Jim Simons 533,300 sh (-55.29%)
Joel Greenblatt 36,084 sh (-89.90%)
Paul Tudor Jones 8,425 sh (-98.17%)
» More
» Details

Insider Trades

Latest Guru Trades with DVA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 Reduce -89.90%0.28%$62.09 - $70.09 $ 57.72-13%36,084
Mario Gabelli 2017-06-30 Add 2.71%$62.09 - $70.09 $ 57.72-13%22,763
Richard Pzena 2017-06-30 Add 2.13%$62.09 - $70.09 $ 57.72-13%3,398
Leucadia National 2017-06-30 Sold Out 0.04%$62.09 - $70.09 $ 57.72-13%0
Joel Greenblatt 2017-03-31 Reduce -18.93%0.07%$62.9 - $70 $ 57.72-13%357,208
Mario Gabelli 2017-03-31 Add 2.31%$62.9 - $70 $ 57.72-13%22,163
Leucadia National 2017-03-31 New Buy0.04%$62.9 - $70 $ 57.72-13%7,135
Joel Greenblatt 2016-12-31 Add 866.37%0.32%$55.16 - $66.59 $ 57.72-7%440,617
Mario Gabelli 2016-12-31 Reduce -33.58%$55.16 - $66.59 $ 57.72-7%21,663
Richard Pzena 2016-12-31 New Buy$55.16 - $66.59 $ 57.72-7%3,327
Arnold Van Den Berg 2016-12-31 Sold Out 0.82%$55.16 - $66.59 $ 57.72-7%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621492    SIC: 8092
Compare:XKLS:5225, NYSE:UHS, ASX:RHC, BKK:BDMS, NAS:WOOF, LSE:NMC, ASX:SHL, LSE:MDC, HAM:CLS1, SZSE:300015, NYSE:EVHC, BKK:BH, NYSE:HLS, NAS:ACHC, NYSE:MD, NYSE:CHE, XSGO:BANMEDICA, NYSE:SEM, JSE:NTC, ASX:HSO » details
Traded in other countries:TRL.Germany,
Headquarter Location:USA
DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.

DaVita is the world's second-largest dialysis provider, with most of its 2,400 clinics based in the U.S. The company treats nearly 200,000 patients with end-stage renal disease. In a 2012 deal valued at nearly $4.4 billion, DaVita merged with HealthCare Partners, one of the largest physician group managers in the U.S., which now represents approximately 25% of consolidated revenue. HCP coordinates care for nearly 800,000 members with a network of thousands of physicians and specialists in California, Florida, Nevada, New Mexico, and Arizona.

Ratios

vs
industry
vs
history
PE Ratio 8.88
DVA's PE Ratio is ranked higher than
93% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. DVA: 8.88 )
Ranked among companies with meaningful PE Ratio only.
DVA' s PE Ratio Range Over the Past 10 Years
Min: 8.41  Med: 18 Max: 58.72
Current: 8.88
8.41
58.72
Forward PE Ratio 14.99
DVA's Forward PE Ratio is ranked higher than
72% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. DVA: 14.99 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 8.88
DVA's PE Ratio without NRI is ranked higher than
94% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. DVA: 8.88 )
Ranked among companies with meaningful PE Ratio without NRI only.
DVA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.41  Med: 17.78 Max: 58.72
Current: 8.88
8.41
58.72
Price-to-Owner-Earnings 7.71
DVA's Price-to-Owner-Earnings is ranked higher than
92% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. DVA: 7.71 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
DVA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.33  Med: 16.53 Max: 668.7
Current: 7.71
7.33
668.7
PB Ratio 2.16
DVA's PB Ratio is ranked higher than
57% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. DVA: 2.16 )
Ranked among companies with meaningful PB Ratio only.
DVA' s PB Ratio Range Over the Past 10 Years
Min: 2.06  Med: 3.17 Max: 4.88
Current: 2.16
2.06
4.88
PS Ratio 0.75
DVA's PS Ratio is ranked higher than
77% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. DVA: 0.75 )
Ranked among companies with meaningful PS Ratio only.
DVA' s PS Ratio Range Over the Past 10 Years
Min: 0.72  Med: 1.14 Max: 1.45
Current: 0.75
0.72
1.45
Price-to-Free-Cash-Flow 9.88
DVA's Price-to-Free-Cash-Flow is ranked higher than
84% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. DVA: 9.88 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
DVA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.51  Med: 14.62 Max: 42.42
Current: 9.88
7.51
42.42
Price-to-Operating-Cash-Flow 5.66
DVA's Price-to-Operating-Cash-Flow is ranked higher than
86% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. DVA: 5.66 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
DVA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.2  Med: 8.79 Max: 15.89
Current: 5.66
5.2
15.89
EV-to-EBIT 7.84
DVA's EV-to-EBIT is ranked higher than
94% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. DVA: 7.84 )
Ranked among companies with meaningful EV-to-EBIT only.
DVA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 11.6 Max: 20.3
Current: 7.84
6.8
20.3
EV-to-EBITDA 5.98
DVA's EV-to-EBITDA is ranked higher than
93% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. DVA: 5.98 )
Ranked among companies with meaningful EV-to-EBITDA only.
DVA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 9.2 Max: 14.4
Current: 5.98
5.5
14.4
EV-to-Revenue 1.29
DVA's EV-to-Revenue is ranked higher than
72% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. DVA: 1.29 )
Ranked among companies with meaningful EV-to-Revenue only.
DVA' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1  Med: 1.7 Max: 2.5
Current: 1.29
1.1
2.5
PEG Ratio 1.05
DVA's PEG Ratio is ranked higher than
84% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. DVA: 1.05 )
Ranked among companies with meaningful PEG Ratio only.
DVA' s PEG Ratio Range Over the Past 10 Years
Min: 0.4  Med: 1.45 Max: 5.59
Current: 1.05
0.4
5.59
Shiller PE Ratio 20.36
DVA's Shiller PE Ratio is ranked higher than
67% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. DVA: 20.36 )
Ranked among companies with meaningful Shiller PE Ratio only.
DVA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.27  Med: 29.18 Max: 54.81
Current: 20.36
19.27
54.81
Current Ratio 1.45
DVA's Current Ratio is ranked higher than
51% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. DVA: 1.45 )
Ranked among companies with meaningful Current Ratio only.
DVA' s Current Ratio Range Over the Past 10 Years
Min: 0.39  Med: 1.86 Max: 5.97
Current: 1.45
0.39
5.97
Quick Ratio 1.38
DVA's Quick Ratio is ranked higher than
53% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. DVA: 1.38 )
Ranked among companies with meaningful Quick Ratio only.
DVA' s Quick Ratio Range Over the Past 10 Years
Min: 0.37  Med: 1.8 Max: 5.97
Current: 1.38
0.37
5.97
Days Inventory 6.23
DVA's Days Inventory is ranked higher than
82% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 16.86 vs. DVA: 6.23 )
Ranked among companies with meaningful Days Inventory only.
DVA' s Days Inventory Range Over the Past 10 Years
Min: 3.72  Med: 6 Max: 8.61
Current: 6.23
3.72
8.61
Days Sales Outstanding 49.91
DVA's Days Sales Outstanding is ranked lower than
61% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. DVA: 49.91 )
Ranked among companies with meaningful Days Sales Outstanding only.
DVA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.53  Med: 62.54 Max: 69.35
Current: 49.91
43.53
69.35
Days Payable 14.62
DVA's Days Payable is ranked lower than
82% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. DVA: 14.62 )
Ranked among companies with meaningful Days Payable only.
DVA' s Days Payable Range Over the Past 10 Years
Min: 14.62  Med: 19.24 Max: 27.07
Current: 14.62
14.62
27.07

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 3.00
DVA's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. DVA: 3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
DVA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -58.4  Med: -0.8 Max: 9.3
Current: 3
-58.4
9.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.63
DVA's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
91% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. DVA: 0.63 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
DVA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.62  Med: 1.15 Max: 9.09
Current: 0.63
0.62
9.09
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.74
DVA's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
86% of the 36 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. DVA: 0.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
DVA' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.53  Med: 1.32 Max: 4.69
Current: 0.74
0.53
4.69
Price-to-Median-PS-Value 0.67
DVA's Price-to-Median-PS-Value is ranked higher than
81% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. DVA: 0.67 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
DVA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.16  Med: 1.09 Max: 5.35
Current: 0.67
0.16
5.35
Price-to-Peter-Lynch-Fair-Value 0.86
DVA's Price-to-Peter-Lynch-Fair-Value is ranked higher than
84% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. DVA: 0.86 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
DVA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.48  Med: 1.29 Max: 8.16
Current: 0.86
0.48
8.16
Earnings Yield (Greenblatt) % 12.80
DVA's Earnings Yield (Greenblatt) % is ranked higher than
95% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. DVA: 12.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
DVA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.9  Med: 8.6 Max: 14.6
Current: 12.8
4.9
14.6
Forward Rate of Return (Yacktman) % 18.18
DVA's Forward Rate of Return (Yacktman) % is ranked higher than
74% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. DVA: 18.18 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
DVA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 12.5  Med: 18.9 Max: 35.4
Current: 18.18
12.5
35.4

More Statistics

Revenue (TTM) (Mil) $15,021.08
EPS (TTM) $ 6.51
Beta1.05
Short Percentage of Float5.42%
52-Week Range $53.58 - 70.16
Shares Outstanding (Mil)191.20

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 15,279 16,102
EPS ($) 3.62 3.77
EPS without NRI ($) 3.62 3.77
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.95%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}